{"transactions":[{"id":825705,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-03-30T16:56:14.000Z","date":"2026-03-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1468,"price":268.38,"value":393981.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":12677.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000124/form4.xml","form_type":"4"}},{"id":825704,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-03-30T16:56:14.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":2968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares acquired on March 26, 2026, pursuant to a performance award granted on May 5, 2023, relating to performance during the three-year period ended December 31, 2025."}],"balance_after":14145.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000124/form4.xml","form_type":"4"}},{"id":825703,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-03-30T16:56:14.000Z","date":"2026-03-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4600,"price":268.38,"value":1234548.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":11177.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000124/form4.xml","form_type":"4"}},{"id":825702,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-03-30T16:56:14.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":9304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025."}],"balance_after":15777.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000124/form4.xml","form_type":"4"}},{"id":906024,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-13T18:13:53.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2358,"derivative":{"underlying":"Common Stock","underlying_shares":806},"source":{"system":"sec-edgar","filing":"0000920148-26-000087","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000087/form4.xml","form_type":"4"}},{"id":906023,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-13T18:13:53.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":259,"price":289.89,"value":75081.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6473.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000087/form4.xml","form_type":"4"}},{"id":906022,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-13T18:13:53.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":806,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."}],"balance_after":6732.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000087/form4.xml","form_type":"4"}},{"id":912912,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-07","kind":"exercise","planned":false,"acquired":false,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3164,"derivative":{"underlying":"Common Stock","underlying_shares":164},"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912911,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-07","kind":"exercise","planned":false,"acquired":false,"shares":517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3328,"derivative":{"underlying":"Common Stock","underlying_shares":517},"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912910,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3845,"derivative":{"underlying":"Common Stock","underlying_shares":743},"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912909,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":53,"price":274.01,"value":14522.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5926.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912908,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":166,"price":274.01,"value":45485.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5979.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912907,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-07","kind":"exercise","planned":false,"acquired":true,"shares":164,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."}],"balance_after":6145.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912906,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-07","kind":"exercise","planned":false,"acquired":true,"shares":517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."}],"balance_after":5981.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912905,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":239,"price":277.2,"value":66250.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5464.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":912904,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2026-02-10T20:07:57.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."}],"balance_after":5703.1426,"source":{"system":"sec-edgar","filing":"0000920148-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000029/form4.xml","form_type":"4"}},{"id":1188389,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-03-31T14:39:25.000Z","date":"2025-03-28","kind":"sale","planned":true,"acquired":false,"shares":2635,"price":231.67,"value":610450.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":4960.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-010624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225010624/form4.xml","form_type":"4"}},{"id":1188388,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-03-31T14:39:25.000Z","date":"2025-03-27","kind":"tax_withholding","planned":true,"acquired":false,"shares":2205,"price":231.67,"value":510832.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":7595.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-010624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225010624/form4.xml","form_type":"4"}},{"id":1188387,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-03-31T14:39:25.000Z","date":"2025-03-27","kind":"grant","planned":true,"acquired":true,"shares":4840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024."}],"balance_after":9800.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-010624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225010624/form4.xml","form_type":"4"}},{"id":1232020,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Non-qualified Stock Options","published_at":"2025-03-04T13:41:49.000Z","date":"2025-02-28","kind":"exercise","planned":true,"acquired":false,"shares":3903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested in three equal annual installments beginning on the date reflected in this column."}],"balance_after":0,"derivative":{"exercise_price":131.43,"exercise_date":"2020-02-12","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":3903},"source":{"system":"sec-edgar","filing":"0001127602-25-007615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225007615/form4.xml","form_type":"4"}},{"id":1232019,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-03-04T13:41:49.000Z","date":"2025-02-28","kind":"sale","planned":true,"acquired":false,"shares":5339,"price":249.23,"value":1330638.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":4960.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-007615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225007615/form4.xml","form_type":"4"}},{"id":1232018,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-03-04T13:41:49.000Z","date":"2025-02-28","kind":"exercise","planned":true,"acquired":true,"shares":3903,"price":131.43,"value":512971.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":10299.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-007615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225007615/form4.xml","form_type":"4"}},{"id":1270221,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-13T16:30:40.000Z","date":"2025-02-11","kind":"exercise","planned":false,"acquired":false,"shares":473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4588,"derivative":{"underlying":"Common Stock","underlying_shares":473},"source":{"system":"sec-edgar","filing":"0001127602-25-004536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004536/form4.xml","form_type":"4"}},{"id":1270220,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-13T16:30:40.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":5061,"derivative":{"underlying":"Common Stock","underlying_shares":2420},"source":{"system":"sec-edgar","filing":"0001127602-25-004536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004536/form4.xml","form_type":"4"}},{"id":1270219,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Non-qualified Stock Options","published_at":"2025-02-13T16:30:40.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":7300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in three equal annual installments beginning on the date reflected in this column."}],"balance_after":7300,"derivative":{"exercise_price":245.14,"exercise_date":"2026-02-11","expiration_date":"2035-02-10","underlying":"Common Stock","underlying_shares":7300},"source":{"system":"sec-edgar","filing":"0001127602-25-004536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004536/form4.xml","form_type":"4"}},{"id":1270218,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-13T16:30:40.000Z","date":"2025-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":134,"price":245.14,"value":32848.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6396.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-004536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004536/form4.xml","form_type":"4"}},{"id":1270217,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-13T16:30:40.000Z","date":"2025-02-11","kind":"exercise","planned":false,"acquired":true,"shares":473,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc.  Common Stock."}],"balance_after":6530.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-004536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004536/form4.xml","form_type":"4"}},{"id":1277288,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2641,"derivative":{"underlying":"Common Stock","underlying_shares":164},"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277287,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2805,"derivative":{"underlying":"Common Stock","underlying_shares":517},"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277286,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":false,"shares":743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3322,"derivative":{"underlying":"Common Stock","underlying_shares":743},"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277285,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":47,"price":246.27,"value":11574.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6057.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277284,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":164,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."}],"balance_after":6104.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277283,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":146,"price":246.27,"value":35955.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5940.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277282,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."}],"balance_after":6086.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277281,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":210,"price":247.74,"value":52025.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":5569.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1277280,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2025-02-10T14:15:48.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":true,"shares":743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. (\"LHI\") Common Stock."}],"balance_after":5779.1426,"source":{"system":"sec-edgar","filing":"0001127602-25-003716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003716/form4.xml","form_type":"4"}},{"id":1551270,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-04-03T12:35:28.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":6477,"price":217.29,"value":1407387.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":5036.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-012006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224012006/form4.xml","form_type":"4"}},{"id":1557825,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2024-03-29T21:32:31.000Z","date":"2024-03-27","kind":"exercise","planned":false,"acquired":false,"shares":11556,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Laboratory Corporation of America Holdings (\"Labcorp\") Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Laboratory Corporation of America Holdings (\"Labcorp\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously reported, in connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the \"EMA\") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"As previously reported, in connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the \"EMA\") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of RSUs held by the reporting person."}],"balance_after":4065,"derivative":{"underlying":"Common Stock","underlying_shares":11556},"source":{"system":"sec-edgar","filing":"0000920148-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000023/primary_doc.xml","form_type":"4"}},{"id":1557824,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-03-29T21:32:31.000Z","date":"2024-03-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":5079,"price":216.57,"value":1099959.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":11513.1426,"source":{"system":"sec-edgar","filing":"0000920148-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000023/primary_doc.xml","form_type":"4"}},{"id":1557823,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-03-29T21:32:31.000Z","date":"2024-03-27","kind":"exercise","planned":false,"acquired":true,"shares":11556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of Laboratory Corporation of America Holdings (\"Labcorp\") Common Stock."}],"balance_after":16592.1426,"source":{"system":"sec-edgar","filing":"0000920148-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014824000023/primary_doc.xml","form_type":"4"}},{"id":1585119,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Non-qualified Stock Options","published_at":"2024-03-11T12:59:08.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":false,"shares":2119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. (\"Fortrea\") by Laboratory Corporation of America Holdings (\"Labcorp\"),\ncalculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. (\"Fortrea\") by Laboratory Corporation of America Holdings (\"Labcorp\"),\ncalculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in three equal annual installments beginning on the date reflected in this column."}],"balance_after":0,"derivative":{"exercise_price":117.09,"exercise_date":"2018-02-07","expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":2119},"source":{"system":"sec-edgar","filing":"0001127602-24-009301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224009301/form4.xml","form_type":"4"}},{"id":1585118,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-03-11T12:59:08.000Z","date":"2024-03-07","kind":"sale","planned":true,"acquired":false,"shares":5048,"price":218.45,"value":1102735.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":5036.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-009301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224009301/form4.xml","form_type":"4"}},{"id":1585117,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-03-11T12:59:08.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":true,"shares":2119,"price":117.09,"value":248113.71,"ownership":{"direct":true},"balance_after":10084.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-009301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224009301/form4.xml","form_type":"4"}},{"id":1647301,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T17:11:29.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":false,"shares":472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":15621,"derivative":{"underlying":"Common Stock","underlying_shares":472},"source":{"system":"sec-edgar","filing":"0001127602-24-004638","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224004638/form4.xml","form_type":"4"}},{"id":1647300,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-13T17:11:29.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":126,"price":227.45,"value":28658.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":7965.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-004638","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224004638/form4.xml","form_type":"4"}},{"id":1647299,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-13T17:11:29.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":true,"shares":472,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":8091.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-004638","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224004638/form4.xml","form_type":"4"}},{"id":1654098,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":false,"shares":163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":16093,"derivative":{"underlying":"Common Stock","underlying_shares":163},"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654097,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":false,"shares":517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":16256,"derivative":{"underlying":"Common Stock","underlying_shares":517},"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654096,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Non-qualified Stock Options","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":6900,"derivative":{"exercise_price":222.28,"exercise_date":"2025-02-06","expiration_date":"2034-02-05","underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654095,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":2230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":16773,"derivative":{"underlying":"Common Stock","underlying_shares":2230},"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654094,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":44,"price":223.71,"value":9843.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":7619.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654093,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":true,"shares":163,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":7663.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654092,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":138,"price":223.71,"value":30871.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":7500.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1654091,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-08T20:18:29.000Z","date":"2024-02-07","kind":"exercise","planned":false,"acquired":true,"shares":517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":7638.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003954/form4.xml","form_type":"4"}},{"id":1657334,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-06T20:52:51.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":false,"shares":495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 2, 2022 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 2, 2022 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 269 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc."}],"balance_after":14543,"derivative":{"underlying":"Common Stock","underlying_shares":495},"source":{"system":"sec-edgar","filing":"0001127602-24-003545","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003545/form4.xml","form_type":"4"}},{"id":1657333,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-06T20:52:51.000Z","date":"2024-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":132,"price":221.54,"value":29243.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Stock withholding to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 70.7404 shares acquired on May 31, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan."}],"balance_after":7121.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-003545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003545/form4.xml","form_type":"4"}},{"id":1657332,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2024-02-06T20:52:51.000Z","date":"2024-02-02","kind":"exercise","planned":false,"acquired":true,"shares":495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 70.7404 shares acquired on May 31, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan."}],"balance_after":7253.1426,"source":{"system":"sec-edgar","filing":"0001127602-24-003545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224003545/form4.xml","form_type":"4"}},{"id":1837888,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2023-07-06T00:06:09.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":11648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Laboratory Corporation of America Holdings (\"Labcorp\"), performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting restricted stock units (\"RSUs\") of Labcorp pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea (the \"EMA\"). The 2021 PSA was converted into a number of time-vesting Labcorp RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting on the 30th day following Labcorp's filing of an annual report on Form 10-K that includes audited financial statements with respect to the 3-year period ending December 31, 2023. Amounts are estimates pending finalization of the adjustment ratio pursuant to the EMA."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the spin-off (\"Spin-Off\") of Fortrea Holdings Inc. (\"Fortrea\") by Laboratory Corporation of America Holdings (\"Labcorp\"), performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the \"2021 PSA\") were converted into time-vesting restricted stock units (\"RSUs\") of Labcorp pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea (the \"EMA\"). The 2021 PSA was converted into a number of time-vesting Labcorp RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting on the 30th day following Labcorp's filing of an annual report on Form 10-K that includes audited financial statements with respect to the 3-year period ending December 31, 2023. Amounts are estimates pending finalization of the adjustment ratio pursuant to the EMA."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":14769,"derivative":{"underlying":"Common Stock","underlying_shares":11648},"source":{"system":"sec-edgar","filing":"0001127602-23-020296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223020296/form4.xml","form_type":"4"}},{"id":1883341,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Non-qualified Stock Options","published_at":"2023-05-22T19:08:08.000Z","date":"2023-05-18","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in three equal annual installments beginning on the date reflected in this column."}],"balance_after":1900,"derivative":{"exercise_price":130.6,"exercise_date":"2018-02-07","expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001127602-23-016422","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223016422/form4.xml","form_type":"4"}},{"id":1883340,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2023-05-22T19:08:08.000Z","date":"2023-05-18","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":216.77,"value":325155.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6687.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-016422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223016422/form4.xml","form_type":"4"}},{"id":1883339,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Common Stock","published_at":"2023-05-22T19:08:08.000Z","date":"2023-05-18","kind":"exercise","planned":true,"acquired":true,"shares":1500,"price":130.6,"value":195900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":8187.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-016422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223016422/form4.xml","form_type":"4"}},{"id":1900042,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Restricted Stock Unit","published_at":"2023-05-09T20:45:39.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3121,"derivative":{"underlying":"Common Stock","underlying_shares":440},"source":{"system":"sec-edgar","filing":"0001127602-23-015024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223015024/form4.xml","form_type":"4"}},{"id":1900041,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, Pres Diagnostics & COO"}}],"security":"Non-qualified Stock Options","published_at":"2023-05-09T20:45:39.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":1400,"derivative":{"exercise_price":223.86,"exercise_date":"2024-02-07","expiration_date":"2033-05-04","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001127602-23-015024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223015024/form4.xml","form_type":"4"}},{"id":1933116,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-04-03T14:05:26.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":3897,"price":225.81,"value":879981.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6687.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-011746","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223011746/form4.xml","form_type":"4"}},{"id":1933115,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-04-03T14:05:26.000Z","date":"2023-03-30","kind":"tax_withholding","planned":true,"acquired":false,"shares":2866,"price":224.7,"value":643990.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":10584.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-011746","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223011746/form4.xml","form_type":"4"}},{"id":1933114,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-04-03T14:05:26.000Z","date":"2023-03-30","kind":"grant","planned":true,"acquired":true,"shares":6763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on March 30, 2023, pursuant to a performance award granted on February 4, 2020, relating to performance during the three-year period ended December 31, 2022."}],"balance_after":13450.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-011746","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223011746/form4.xml","form_type":"4"}},{"id":2012048,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-16T17:51:06.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":309,"price":247.63,"value":76517.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6687.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-005485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223005485/form4.xml","form_type":"4"}},{"id":2017663,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2023-02-14T19:54:11.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2681,"derivative":{"underlying":"Common Stock","underlying_shares":423},"source":{"system":"sec-edgar","filing":"0001127602-23-005100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223005100/form4.xml","form_type":"4"}},{"id":2017662,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-14T19:54:11.000Z","date":"2023-02-13","kind":"tax_withholding","acquired":false,"shares":114,"price":248.13,"value":28286.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6996.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-005100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223005100/form4.xml","form_type":"4"}},{"id":2017661,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-14T19:54:11.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":7110.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-005100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223005100/form4.xml","form_type":"4"}},{"id":2025256,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Non-qualified Stock Options","published_at":"2023-02-09T14:04:51.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":4400,"derivative":{"exercise_price":247.24,"exercise_date":"2024-02-07","expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001127602-23-004096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223004096/form4.xml","form_type":"4"}},{"id":2025255,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2023-02-09T14:04:51.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":1390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3104,"derivative":{"underlying":"Common Stock","underlying_shares":1390},"source":{"system":"sec-edgar","filing":"0001127602-23-004096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223004096/form4.xml","form_type":"4"}},{"id":2025254,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-09T14:04:51.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":409,"price":243.01,"value":99391.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6687.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-004096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223004096/form4.xml","form_type":"4"}},{"id":2029270,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2023-02-07T19:50:16.000Z","date":"2023-02-04","kind":"exercise","acquired":false,"shares":560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":1714,"derivative":{"underlying":"Common Stock","underlying_shares":560},"source":{"system":"sec-edgar","filing":"0001127602-23-003700","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003700/form4.xml","form_type":"4"}},{"id":2029269,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-07T19:50:16.000Z","date":"2023-02-06","kind":"tax_withholding","acquired":false,"shares":151,"price":244.5,"value":36919.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":7096.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-003700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003700/form4.xml","form_type":"4"}},{"id":2029268,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-07T19:50:16.000Z","date":"2023-02-04","kind":"exercise","acquired":true,"shares":560,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":7247.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-003700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003700/form4.xml","form_type":"4"}},{"id":2031122,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2023-02-06T20:51:51.000Z","date":"2023-02-02","kind":"exercise","acquired":false,"shares":443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2274,"derivative":{"underlying":"Common Stock","underlying_shares":443},"source":{"system":"sec-edgar","filing":"0001127602-23-003538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003538/form4.xml","form_type":"4"}},{"id":2031121,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-06T20:51:51.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":324,"price":253.9,"value":82263.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6687.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-003538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003538/form4.xml","form_type":"4"}},{"id":2031120,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-06T20:51:51.000Z","date":"2023-02-02","kind":"tax_withholding","acquired":false,"shares":119,"price":254.99,"value":30343.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":7011.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-003538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003538/form4.xml","form_type":"4"}},{"id":2031119,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2023-02-06T20:51:51.000Z","date":"2023-02-02","kind":"exercise","acquired":true,"shares":443,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":7130.4022,"source":{"system":"sec-edgar","filing":"0001127602-23-003538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760223003538/form4.xml","form_type":"4"}},{"id":2120388,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-11-10T13:40:02.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":1116,"price":232.67,"value":259659.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6687.4022,"source":{"system":"sec-edgar","filing":"0001127602-22-025222","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222025222/form4.xml","form_type":"4"}},{"id":2122741,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2022-11-08T21:27:31.000Z","date":"2022-11-05","kind":"exercise","acquired":false,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":2717,"derivative":{"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001127602-22-025109","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222025109/form4.xml","form_type":"4"}},{"id":2122740,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-11-08T21:27:31.000Z","date":"2022-11-07","kind":"tax_withholding","acquired":false,"shares":894,"price":233.77,"value":208990.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Stock withholding to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan."}],"balance_after":7803.4022,"source":{"system":"sec-edgar","filing":"0001127602-22-025109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222025109/form4.xml","form_type":"4"}},{"id":2122739,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-11-08T21:27:31.000Z","date":"2022-11-05","kind":"exercise","acquired":true,"shares":2010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan."}],"balance_after":8697.4022,"source":{"system":"sec-edgar","filing":"0001127602-22-025109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222025109/form4.xml","form_type":"4"}},{"id":2313459,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-03-31T14:24:43.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":2356,"price":277.11,"value":652871.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6605.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-010699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222010699/form4.xml","form_type":"4"}},{"id":2315881,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-03-29T16:03:18.000Z","date":"2022-03-28","kind":"tax_withholding","acquired":false,"shares":1885,"price":276.42,"value":521051.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":8961.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-010502","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222010502/form4.xml","form_type":"4"}},{"id":2315880,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-03-29T16:03:18.000Z","date":"2022-03-27","kind":"grant","acquired":true,"shares":4241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on March 27, 2022, pursuant to a performance award granted on February 12, 2019, relating to performance during the three-year period ended December 31, 2021."}],"balance_after":10846.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-010502","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222010502/form4.xml","form_type":"4"}},{"id":2389695,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-17T20:05:19.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":207,"price":273.98,"value":56713.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6605.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-005446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222005446/form4.xml","form_type":"4"}},{"id":2395379,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:38:43.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2020 and are now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2020 and are now fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4727,"derivative":{"underlying":"Common Stock","underlying_shares":284},"source":{"system":"sec-edgar","filing":"0001127602-22-005020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222005020/form4.xml","form_type":"4"}},{"id":2395378,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Non-qualified Stock Options","published_at":"2022-02-15T21:38:43.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":4500,"derivative":{"exercise_price":276.26,"exercise_date":"2023-02-11","expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001127602-22-005020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222005020/form4.xml","form_type":"4"}},{"id":2395377,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:38:43.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":1270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":5011,"derivative":{"underlying":"Common Stock","underlying_shares":1270},"source":{"system":"sec-edgar","filing":"0001127602-22-005020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222005020/form4.xml","form_type":"4"}},{"id":2395376,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-15T21:38:43.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":77,"price":272.68,"value":20996.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6812.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222005020/form4.xml","form_type":"4"}},{"id":2395375,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-15T21:38:43.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":284,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":6889.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222005020/form4.xml","form_type":"4"}},{"id":2408916,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2022-02-08T16:08:32.000Z","date":"2022-02-04","kind":"exercise","acquired":false,"shares":560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3741,"derivative":{"underlying":"Common Stock","underlying_shares":560},"source":{"system":"sec-edgar","filing":"0001127602-22-003647","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003647/form4.xml","form_type":"4"}},{"id":2408915,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-08T16:08:32.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":204,"price":277.38,"value":56585.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6605.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-003647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003647/form4.xml","form_type":"4"}},{"id":2408914,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-08T16:08:32.000Z","date":"2022-02-04","kind":"tax_withholding","acquired":false,"shares":152,"price":277.48,"value":42176.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6809.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-003647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003647/form4.xml","form_type":"4"}},{"id":2408913,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-08T16:08:32.000Z","date":"2022-02-04","kind":"exercise","acquired":true,"shares":560,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."}],"balance_after":6961.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-003647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003647/form4.xml","form_type":"4"}},{"id":2412158,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Restricted Stock Unit","published_at":"2022-02-04T17:15:41.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4301,"derivative":{"underlying":"Common Stock","underlying_shares":443},"source":{"system":"sec-edgar","filing":"0001127602-22-003291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003291/form4.xml","form_type":"4"}},{"id":2412157,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-04T17:15:41.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":161,"price":271.81,"value":43761.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":6401.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-003291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003291/form4.xml","form_type":"4"}},{"id":2412156,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":55441,"kind":"person","name":"Schroeder Mark S","position":1,"cik":"0001793112","reported_name":"Schroeder Mark S","relationship":{"officer":true,"officer_title":"EVP, President-Diagnostics Lab"}}],"security":"Common Stock","published_at":"2022-02-04T17:15:41.000Z","date":"2022-02-02","kind":"tax_withholding","acquired":false,"shares":121,"price":273.18,"value":33054.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":6562.4989,"source":{"system":"sec-edgar","filing":"0001127602-22-003291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760222003291/form4.xml","form_type":"4"}}],"next_cursor":"2022-02-04T17:15:41.000000Z,2412156"}